The survival period of patients with Parkinson’s disease can range from several years to more than 20 years. Parkinson’s disease is a neurodegenerative disease that commonly affects middle-aged and older adults. Clinical manifestations include mainly resting tremor, bradykinesia, myotonia and postural balance disorders. Generally, if patients do not undergo early and effective treatment, their symptoms can deteriorate rapidly and they can survive for only 3-5 years. If diagnosed early and treated with medication, survival can be extended accordingly. Currently, the commonly used drugs for the treatment of Parkinson’s are compound levodopa standard tablets, Morpholog, and Silegiline, which can effectively improve the patient’s symptoms and quality of life. As the efficacy of long-term drug treatment decreases and patients experience drug side effects, surgical treatment may be an option. The main surgical treatment methods are neurodesis and deep brain electrical stimulation. Parkinson’s disease is not yet curable, but through active symptomatic treatment, the quality of life of patients can be improved to a certain extent, and the survival period can be appropriately extended. Patients with advanced motor function limitation are bedridden for a long time, and special attention should be paid to the occurrence of complications such as pneumonia to avoid threatening patients’ lives.